Field study to assess the efficacy of SUISENG® on three South Korean farms

Inicio Conocimiento Field study to assess the efficacy of SUISENG® on three South Korean farms

Field study to assess the efficacy of SUISENG® on three South Korean farms

In some studies conducted in Europe, diarrhoea is estimated to account for 5-24% of overall pre-weaning mortality and to reduce average daily gain (ADG) by 8-14 g per day. Based on these effects, the cost of neonatal diarrhoea was recently estimated to be 134 € per sow per year. The aim of this study was to assess the financial impact of SUISENG® vaccination under field conditions on a commercial farm located in Portugal.

Sobre este artículo

Apareció en

IPVS Congress, 2016

Resumen

The economic benefit of vaccination with SUISENG® was demonstrated, not only because of the cost of losses caused by neonatal diarrhoea, but also because of the increased cost resulting from antibiotic treatment of animals in the non-vaccinated groups. The cost at the end of lactation was therefore reduced and the efficacy of vaccination with SUISENG® was demonstrated.

Servicios relacionados

Productos relacionados

Compartir en